Skip to main content

Table 1 Overview of the 33 TCGA studies used in this analysis

From: Identification and ranking of recurrent neo-epitopes in cancer

Project name Number of patients Variants per patients Missense variant per patient Recurrent variants Strong binders
  Total With clinical data Average Median Average Median   
TCGA-BLCA 412 412 326 226 157 109 22 14
TCGA-BRCA 986 986 123 62 50 25 8 10
TCGA-CESC 289 289 358 157 143 62 17 16
TCGA-COAD 399 397 666 176 288 82 41 34
TCGA-ESCA 184 184 246 187 95 73 80 72
TCGA-GBM 393 390 212 70 93 36 15 5
TCGA-HNSC 508 508 201 139 97 66 14 3
TCGA-KIRC 336 336 79 69 33 31 0 0
TCGA-KIRP 281 281 85 82 39 38 5 2
TCGA-LAML 143 143 69 15 16 6 14 7
TCGA-LGG 508 507 70 36 33 16 14 0
TCGA-LIHC 364 364 149 120 70 58 11 16
TCGA-LUAD 567 515 367 242 180 113 7 0
TCGA-LUSC 492 492 368 301 187 153 20 19
TCGA-OV 436 435 173 121 58 47 10 7
TCGA-PAAD 178 178 168 50 77 19 24 12
TCGA-PCPG 179 179 13 12 5 4 8 5
TCGA-PRAD 495 495 59 35 27 15 3 7
TCGA-READ 137 136 475 148 232 70 320 186
TCGA-SARC 237 237 119 70 45 26 2 0
TCGA-SKCM 467 467 841 472 413 229 266 220
TCGA-STAD 437 437 488 157 211 74 17 14
TCGA-TGCT 144 128 23 21 9 8 9 6
TCGA-THCA 492 492 22 12 6 5 4 3
TCGA-THYM 123 123 39 24 10 4 6 2
TCGA-UCEC 530 530 1672 149 708 54 118 109
TCGA-ACC 92 92 117 36 0 0 0 0
TCGA-CHOL 51 45 110 62 0 0 0 0
TCGA-DLBC 37 37 173 157 0 0 0 0
TCGA-KICH 66 66 44 25 0 0 0 0
TCGA-MESO 82 82 47 44 0 0 0 0
TCGA-UCS 57 57 183 67 0 0 0 0
TCGA-UVM 80 80 23 16 0 0 0 0
Total 10182 10100 Total number: 3155183 Total number: 1384531 1055 769
  1. The 7 studies displayed at the bottom have not been used for the determination of recurrent vairants, as the number of patients is less than 100. The number of strong binders includes all occurrences of neo-epitopes candidates, so a candidate may be counted multiple times when it is predicted to be binding several HLA-1 types